MAPT anticorps (AA 266-315)
Aperçu rapide pour MAPT anticorps (AA 266-315) (ABIN2889098)
Antigène
Voir toutes MAPT AnticorpsReactivité
Hôte
Clonalité
Conjugué
Application
-
-
Épitope
- AA 266-315
-
Specificité
- Tau (Ab-519/202) Antibody detects endogenous levels of total Tau protein.
-
Purification
- Immunoaffinity purified
-
Immunogène
-
Synthetic peptide from human Tau (aa266-315).
Type of Immunogen: Synthetic peptide -
Isotype
- IgG
-
-
-
-
Indications d'application
- Approved: Peptide-ELISA (1:20000), WB (1:500 - 1:1000)
-
Commentaires
-
Target Species of Antibody: Human
-
Restrictions
- For Research Use only
-
-
-
Format
- Liquid
-
Concentration
- Lot specific
-
Buffer
- PBS (without Mg2+, Ca2+), pH 7.4, 150 mM sodium chloride, 0.02 % sodium azide, 50 % glycerol
-
Agent conservateur
- Sodium azide
-
Précaution d'utilisation
- This product contains Sodium azide: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.
-
Stock
- -20 °C
-
Stockage commentaire
- Store at -20°C for up to 1 year.
-
Date de péremption
- 12 months
-
-
- MAPT (Microtubule-Associated Protein tau (MAPT))
-
Autre désignation
- MAPT / tau
-
Sujet
-
Name/Gene ID: MAPT
Synonyms: MAPT, FTDP-17, MSTD, Neurofibrillary tangle protein, PHF-tau, MTBT2, PPND, DDPAC, MAPTL, MTBT1, Paired helical filament-tau, TAU -
ID gène
- 4137
-
Pathways
- Signalisation MAPK, Dynamique des Microtubules, M Phase, Regulation of Cell Size
Antigène
-